Atlantis Healthcare

Established in 1996, Atlantis Healthcare is a global leader in treatment adherence and patient self-management. Atlantis provides digital healthcare solutions to address the issues of treatment non-adherence by applying its core expertise in behavior change to design and implement patient support programs which help patients, healthcare systems and the pharmaceutical industry measure and improve health outcomes. With offices in the United Kingdom, Germany, Spain, Australia, USA and New Zealand, we create engaging support programs for patients and clinicians which are delivered by a world class team specializing in health psychology. Using our interventional communication experience and proprietary technology platform, each patient support program is tailored to address a patient's specific barriers to treatment adherence and self-management. This personalized program approach captures the profile of an individual patient, their beliefs surrounding illness and treatment plus their specific needs in terms of support. This ensures that program interventions address the underlying barriers to treatment adherence on an individual patient basis in order to deliver lasting behavior change. Atlantis Healthcare has treated over a million patients and delivered over 100 international support programs across 90+ disease states including: Alzheimer’s disease, asthma, breast cancer, prostate cancer, lung cancer, skin cancer, Leukaemia, COPD, diabetes, erectile dysfunction, glaucoma, gout, growth hormone deficiency, haemophilia, hearing loss, hepatitis C, incontinence, osteoporosis, pain, rheumatoid arthritis and wet AMD, among others, as well as programs to support health screenings and blood donor management.